IFP Advisors
XENE icon

IFP Advisors’s Xenon Pharmaceuticals XENE Stock Holding History

IFP Advisors’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$72K Buy
1,937
+66
+4% +$3.92K ﹤0.01% 2163
2026
Q2 		$113K Hold
1,871
– – ﹤0.01% 1896
2026
Q1 		$109K Sell
1,871
-6
-0.3% -$276 ﹤0.01% 1791
2025
Q4 		$84.1K Sell
1,877
-31
-2% -$1.3K ﹤0.01% 1908
2025
Q3 		$76.6K Buy
1,908
+43
+2% +$1.51K ﹤0.01% 1851
2025
Q2 		$61.5K Sell
1,865
-56
-3% -$1.83K ﹤0.01% 1937
2025
Q1 		$64.6K Sell
1,921
-37
-2% -$1.4K ﹤0.01% 1766
2024
Q4 		$76.9K Sell
1,958
-19
-1% -$786 ﹤0.01% 1602
2024
Q3 		$77.8K Sell
1,977
-125
-6% -$5.04K ﹤0.01% 1518
2024
Q2 		$82K Sell
2,102
-19
-0.9% -$759 ﹤0.01% 1445
2024
Q1 		$91.3K Sell
2,121
-27
-1% -$1.24K ﹤0.01% 1332
2023
Q4 		$98.9K Sell
2,148
-30
-1% -$1.06K ﹤0.01% 1248
2023
Q3 		$74.4K Hold
2,178
– – ﹤0.01% 1397
2023
Q2 		$83.8K Buy
2,178
+1,178
+118% +$46.8K ﹤0.01% 1395
2023
Q1 		$5.7K Hold
1,000
– – ﹤0.01% 2510
2022
Q4 		$6K Hold
1,000
– – ﹤0.01% 3732
2022
Q3 		$6K Hold
1,000
– – ﹤0.01% 3968
2022
Q2 		$6K Hold
1,000
– – ﹤0.01% 3723
2022
Q1 		$6K Hold
1,000
– – ﹤0.01% 3721
2021
Q4 		$31K Hold
1,000
– – ﹤0.01% 1757
2021
Q3 		$15K Hold
1,000
– – ﹤0.01% 2120
2021
Q2 		$19K Hold
1,000
– – ﹤0.01% 1962
2021
Q1 		$18K Hold
1,000
– – ﹤0.01% 1899
2020
Q4 		$15K Hold
1,000
– – ﹤0.01% 1914
2020
Q3 		$11K Hold
1,000
– – ﹤0.01% 1880
2020
Q2 		$12K Hold
1,000
– – ﹤0.01% 1765
2020
Q1 		$11K Buy
+1,000
New +$14.2K ﹤0.01% 1741

Other funds holding XENE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

IFP Advisors's XENE Position: Q3 2026 in Review

IFP Advisors increased its Xenon Pharmaceuticals (XENE) stake by 3.5% in Q3 2026, buying an estimated $3.92K and bringing the position to 1,937 shares worth $72K. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

IFP Advisors first reported a position in XENE in Q1 2020 and has held it in 27 quarters since. The position peaked at $113K in Q2 2026. 90 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • IFP Advisors held 1,937 shares of Xenon Pharmaceuticals worth $72K as of Q3 2026.
  • IFP Advisors bought 66 Xenon Pharmaceuticals shares in Q3 2026, an estimated $3.92K.
  • Xenon Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2163 holding.
  • IFP Advisors first reported a position in Xenon Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
  • IFP Advisors's Xenon Pharmaceuticals position peaked at $113K in Q2 2026.
  • 90 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.